Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Dendritic Cell Sarcoma, Interdigitating 76Sarcoma 72Burkitt Lymphoma 59Lymphoma 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 56Lymphoma, Large B-Cell, Diffuse 54Lymphoma, Non-Hodgkin 53Lymphoma, Follicular 49Lymphoma, Mantle-Cell 48Leukemia 48Lymphoma, Large-Cell, Immunoblastic 47Leukemia, Lymphocytic, Chronic, B-Cell 46Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myeloid, Acute 43Hodgkin Disease 42Myelodysplastic Syndromes 41Multiple Myeloma 40Recurrence 39Leukemia, Myeloid, Chronic-Phase 32Leukemia, Myeloid, Accelerated Phase 31Blast Crisis 30Neoplasms, Plasma Cell 28Sarcoma, Ewing 25Rhabdomyosarcoma 25Osteosarcoma 24Myeloproliferative Disorders 24Neuroblastoma 23Leukemia, Myelomonocytic, Chronic 21Congenital Abnormalities 21Melanoma 20

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gaucher Disease × Cyclophosphamide × Sarcoma × Clear all
NCT03721068 2026-03-27

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Recruiting
18 enrolled
CNSSarcoma

Gaucher Disease, Neuroblastoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡